drugset / Trial / NCT06116045
Evaluation of the Efficacy, Safety and Tolerability of BZ371A in Women with Sexual Arousal Disorder
RandomizedCrossoverQuadruple-blindTreatment
Summary
To determine the efficacy in increasing sexual arousal, safety and tolerability of BZ371A in gel form applied to women with sexual arousal disorder.
Timeline
- Start
- 2024-10-01
- Primary completion
- 2025-02-01
- Completion
- 2025-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BZ371A | Unknown | 2.5 mg | Topical |
| Subject | BZ371A | Unknown | 5 mg | Topical |
| Subject | BZ371A | Unknown | 7.5 mg | Topical |